Subtype

Ovarian Neoplasm

Non-malignant746 active trials5 approved drugs94 evidence items

NCIt: C4984
MeSH: D010051

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (174)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 76–100 of 174 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Senescence-associated mitochondrial dysfunction as a therapeutic target in ovarian cancer: Challenges and opportunities.
Hanieh Sadat Khalili, Banafshe Abadi, Nima Rezaei · Eur J Pharmacol · Sep 10, 2026 · PMID 42594984 · candidate dictionary pubmed
A 177Lu-Labeled Circular Bivalent Aptamer for PTK7-Targeting Radionuclide Therapy in Ovarian Cancer and Orthotopic Hepatoblastoma.
Xiaoning Tong, Yi He, Heng Liu et al. · J Med Chem · Sep 10, 2026 · PMID 42720498 · candidate dictionary pubmed
Bright rRNA-Associated Merocyanine Probes Highlight Tumor Extensions in Ovarian Cancer.
Devorah Corn, Alon Boocholez, Prasenjit Das et al. · J Med Chem · Sep 10, 2026 · PMID 42720477 · candidate dictionary pubmed
Associations Between Pre-diagnostic Plasma Metabolites and Ovarian Cancer: A Prospective Case-Cohort Analysis in the Cancer Prevention Study-3.
Brigitte A Pfluger, Matthew Masters, Nancy B Nguyen et al. · Cancer Epidemiol Biomarkers Prev · Sep 10, 2026 · PMID 42720260 · candidate dictionary pubmed
Trigonelline reverses cisplatin resistance in ovarian cancer cells by modulating ferroptosis via the Nrf2/GPX4 pathway.
Jing Li, Xiaoxiao Wang, Liya Tu et al. · Toxicon · Sep 10, 2026 · PMID 42722238 · candidate dictionary pubmed
Prognostic impact of systematic lymphadenectomy during interval debulking surgery after neoadjuvant chemotherapy in stage III ovarian cancer: A 38-institution retrospective cohort study using inverse probability of treatment weighting.
Yuki Iida, Mayumi Kobayashi-Kato, Hisashi Noma et al. · Eur J Surg Oncol · Sep 10, 2026 · PMID 42731258 · candidate

dictionary

pubmed

Bacteria-Based Ammunition for Cascade-Amplified Chemoimmunotherapy of Ovarian Cancer.

Zhuorong Miao, Yafang Lu, Yu Zhang et al. · Nano Lett · Sep 9, 2026 · PMID 42715039 · candidate dictionary pubmed

The DNA/RNA Helicase SETX Maintains R-Loop Homeostasis to Promote Chemoresistance in Ovarian Cancer.

Zi-Wei Hu, Tu-Nan Xu, Zi-Ying Wang et al. · Cancer Sci · Sep 9, 2026 · PMID 42713672 · candidate dictionary pubmed

Evolving dynamics of ovarian cancer in midlife women: A three-decade age-period-cohort study.

Rui Yang, Chaoyan Yue, Xiang Xu et al. · Int J Gynaecol Obstet · Sep 9, 2026 · PMID 42712225 · candidate dictionary pubmed

Characteristics and influencing factors of demoralization in ovarian cancer: a latent profile analysis.

Yuanyuan Pang, Hongxiu Liu, Qifan Ding et al. · Support Care Cancer · Sep 8, 2026 · PMID 42709228 · candidate dictionary pubmed

Birinapant enhances cisplatin sensitivity in epithelial ovarian cancer through modulation of apoptotic and survival signaling pathways.

Elham Shahnazi, Arman Rostamlou, Aras Gezer et al. · Cancer Chemother Pharmacol · Sep 8, 2026 · PMID 42709209 · candidate dictionary pubmed

Hope is linked with more favorable tumor molecular signatures in serous ovarian cancer.

Susan K Lutgendorf, Benjamin W Corn, Premal H Thaker et al. · Brain Behav Immun · Sep 8, 2026 · PMID 42710689 · candidate dictionary pubmed

PARP16 is a Druggable Regulator of Ribosome MARylation and Protein Homeostasis in Ovarian Cancer Cells.

Sridevi Challa, Morgan Dasovich, Jonathan C Abshier et al. · J Biol Chem · Sep 8, 2026 · PMID 42710679 · candidate dictionary pubmed

Evaluation of Phytocannabinoids as Antitumor Agents against Ovarian Cancer Cells in Combination with Carboplatin.

Uri Warter, Yuval Yogev, David C Nwobodo et al. · ACS Omega · Sep 8, 2026 · PMID 42729764 · candidate dictionary pubmed

Transcriptomic analysis of a phase 1 trial for intraperitoneal monocytes plus IFNs in ovarian cancer reveals support and recruitment of cell-mediated immunity.

Franklin Ning, Emily San Andres-Montalvan, Thomas J Meyer et al. · J Immunother Cancer · Sep 7, 2026 · PMID 42705863 · candidate dictionary pubmed

SMPDM3B-loaded extracellular vesicles from tumor-associated macrophages drive ovarian cancer chemoresistance by inhibiting the cGAS/STING pathway.

Xin Liang, Hanlu Yang, Lan Hong · Arch Biochem Biophys · Sep 7, 2026 · PMID 42705430 · candidate dictionary pubmed

Correction: Ferroptosis and chemotherapy resistance in ovarian cancer: molecular mechanisms and therapeutic opportunities.

Shuqing Li, Lina Yang, Zhiling Zhu · J Ovarian Res · Sep 7, 2026 · PMID 42702713 · candidate dictionary pubmed

Patient-derived organoids as predictor of clinical response in ovarian cancer: a systematic review.

Merel Vegter, Prakriti Garkhail, Gatske M Nieuwenhuyzen-de Boer et al. · Transl Oncol · Sep 6, 2026 · PMID 42702147 · candidate dictionary pubmed

Temporal trends in short-term mortality in more than 5000 patients with early-stage ovarian cancer in Denmark and Sweden.

Ida Hustad Andresen, Guoqiao Zheng, Louise Baandrup et al. · Eur J Obstet Gynecol Reprod Biol · Sep 6, 2026 · PMID 42715677 · candidate dictionary pubmed

VEGFR2-targeted NIR-II fluorescent probe for precise imaging and surgical navigation of ovarian cancer.

Nannan Tian, Shuxian Zhao, Fan Xu et al. · Bioorg Chem · Sep 5, 2026 · PMID 42184579 · candidate dictionary pubmed

Diagnosis of ovarian cancer using multiple biomarkers of CA 125, CA153, CA 19-9, CEA, HE4 and ROMA index.

Chun-Feng Ren, Gen-Hui Ren, Li-Wei Ma et al. · Ann Biol Clin (Paris) · Sep 4, 2026 · PMID 42698297 · candidate dictionary pubmed

Flavonoids as promising natural therapeutics in ovarian cancer treatment: A comprehensive review.

Yuan Chen, Xiaohua Tang, Yurong Zou et al. · J Steroid Biochem Mol Biol · Sep 4, 2026 · PMID 42697337 · candidate dictionary pubmed

Targeted Modulation of Abundant Proteins Enhances Proteomic Profiling of Ovarian Cancer Ascites: A Pilot Technical Workflow Comparison.

Zongkai Peng, James Lausen, Doris M Benbrook et al. · J Proteome Res · Sep 4, 2026 · PMID 42695897 · candidate dictionary pubmed

Prevalence of BRCA1/2 variants in an Ovarian Cancer Cohort: outcomes from a Nationwide Testing Program.

Ciara S McNevin, Kate Murphy, Pierre Murchan et al. · Eur J Hum Genet · Sep 3, 2026 · PMID 42693191 · candidate dictionary pubmed

Redirected T-cell cytotoxicity identifies BRD9-PTGES axis as an immune-sensitising vulnerability in ovarian cancer.

Shanni Guo, Peng Shi, Changrui Yang et al. · Biochem Biophys Res Commun · Sep 3, 2026 · PMID 42349121 · candidate dictionary pubmed